These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 21988996)
1. Moving ahead an HIV vaccine: use both arms to beat HIV. Walker BD; Ahmed R; Plotkin S Nat Med; 2011 Oct; 17(10):1194-5. PubMed ID: 21988996 [No Abstract] [Full Text] [Related]
2. Vaccinology: Persistence pays off. Johnson RP Nature; 2011 May; 473(7348):456-7. PubMed ID: 21614068 [TBL] [Abstract][Full Text] [Related]
3. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828 [TBL] [Abstract][Full Text] [Related]
5. Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. Roederer M; Keele BF; Schmidt SD; Mason RD; Welles HC; Fischer W; Labranche C; Foulds KE; Louder MK; Yang ZY; Todd JP; Buzby AP; Mach LV; Shen L; Seaton KE; Ward BM; Bailer RT; Gottardo R; Gu W; Ferrari G; Alam SM; Denny TN; Montefiori DC; Tomaras GD; Korber BT; Nason MC; Seder RA; Koup RA; Letvin NL; Rao SS; Nabel GJ; Mascola JR Nature; 2014 Jan; 505(7484):502-8. PubMed ID: 24352234 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes. Egan MA; Chong SY; Rose NF; Megati S; Lopez KJ; Schadeck EB; Johnson JE; Masood A; Piacente P; Druilhet RE; Barras PW; Hasselschwert DL; Reilly P; Mishkin EM; Montefiori DC; Lewis MG; Clarke DK; Hendry RM; Marx PA; Eldridge JH; Udem SA; Israel ZR; Rose JK AIDS Res Hum Retroviruses; 2004 Sep; 20(9):989-1004. PubMed ID: 15585086 [TBL] [Abstract][Full Text] [Related]
7. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Gautam R; Nishimura Y; Pegu A; Nason MC; Klein F; Gazumyan A; Golijanin J; Buckler-White A; Sadjadpour R; Wang K; Mankoff Z; Schmidt SD; Lifson JD; Mascola JR; Nussenzweig MC; Martin MA Nature; 2016 May; 533(7601):105-109. PubMed ID: 27120156 [TBL] [Abstract][Full Text] [Related]
8. [Towards a vaccine against HIV: antibodies raised by a gp41 peptide neutralize the virus and inhibit pathogenesis]. Vieillard V; Debré P Biol Aujourdhui; 2015; 209(2):161-6. PubMed ID: 26514385 [TBL] [Abstract][Full Text] [Related]
9. Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody. Burton DR; Hessell AJ; Keele BF; Klasse PJ; Ketas TA; Moldt B; Dunlop DC; Poignard P; Doyle LA; Cavacini L; Veazey RS; Moore JP Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11181-6. PubMed ID: 21690411 [TBL] [Abstract][Full Text] [Related]
10. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques. Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T J Gen Virol; 2007 Feb; 88(Pt 2):652-659. PubMed ID: 17251584 [TBL] [Abstract][Full Text] [Related]
11. Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. Xiao P; Zhao J; Patterson LJ; Brocca-Cofano E; Venzon D; Kozlowski PA; Hidajat R; Demberg T; Robert-Guroff M J Virol; 2010 Jul; 84(14):7161-73. PubMed ID: 20444898 [TBL] [Abstract][Full Text] [Related]